Dobutamine
- Generic Name
- Dobutamine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C18H23NO3
- CAS Number
- 34368-04-2
- Unique Ingredient Identifier
- 3S12J47372
- Background
A beta-1 agonist catecholamine that has cardiac stimulant action without evoking vasoconstriction or tachycardia. It is proposed as a cardiotonic after myocardial infarction or open heart surgery.
- Indication
Indicated when parenteral therapy is necessary for inotropic support in the short-term treatment of patients with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures.
- Associated Conditions
- Cardiac Decompensation, Coronary Artery Disease (CAD)
- Associated Therapies
- Intravenous inotropic therapy
Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure.
- Conditions
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2007-11-20
- Lead Sponsor
- Abbott
- Target Recruit Count
- 1300
- Registration Number
- NCT00348504
- Locations
- 🇺🇸
Global Medical Information - Abbott, Abbott Park, Illinois, United States
Intravenous Allopurinol to Improve Heart Function in Individuals With Dilated Cardiomyopathy
- Conditions
- Interventions
- First Posted Date
- 2006-01-24
- Last Posted Date
- 2013-06-19
- Lead Sponsor
- University of Pennsylvania
- Registration Number
- NCT00281255
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
DOCICAR: Cardiac Dysfunction in Cirrhosis
- Conditions
- First Posted Date
- 2005-11-08
- Last Posted Date
- 2007-11-01
- Lead Sponsor
- Hvidovre University Hospital
- Registration Number
- NCT00250315
- Locations
- 🇩🇰
Hvidovre University Hospital, Copenhagen, Hvidovre, Denmark
Levosimendan Versus Dobutamine in Shock Patients
- Conditions
- First Posted Date
- 2004-10-07
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Wentworth Area Health Services
- Target Recruit Count
- 40
- Registration Number
- NCT00093301
- Locations
- 🇦🇺
Intensive Care Unit, Nepean Hospital, Penrith, New South Wales, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.